Add BrightSurf on Google Email

How rituximab affects T cells in kidney disease

Researchers found that rituximab treatment increases mitochondrial energy production and reduces cell stress in T cells, leading to improved response rates in patients with nephrotic syndrome. This discovery could help predict patient response to treatment and identify suitable candidates for early remission.

SourceNagoya University·JournaliScience·TypeObservational study·DateSep 10, 2026

Topical steroid withdrawal diagnostic criteria defined by NIH researchers

Researchers at NIH identified characteristic symptoms of topical steroid withdrawal (TSW), including elevated nicotinamide adenine dinucleotide (NAD+) levels, which can be diagnosed using provisional criteria. TSW treatment may involve mitochondrial complex I-blocking drugs, such as metformin or berberine.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalJournal of Investigative Dermatology·DateMar 14, 2025

Unveiling the intricate mechanisms behind oxysterol-induced cell death

Researchers at Doshisha University reveal that 25-hydroxycholesterol causes a specific type of cell death called ferroptosis, which could contribute to various diseases. The study identifies two key mechanisms by which 25-OHC induces ferroptosis, including inhibition of cellular pathways and disruption of antioxidant systems.

SourceDoshisha University·JournalFree Radical Biology and Medicine·TypeExperimental study·DateFeb 20, 2025

Painful skin when tapering cortisone cream

A Swedish study found that topical steroid withdrawal (TSW) is characterized by symptoms such as redness, pain, and itching, often accompanied by sleep problems. The study aimed to understand the phenomenon of TSW, which many patients consider a cortisone dependence.

SourceUniversity of Gothenburg·JournalActa Dermato Venereologica·TypeSurvey·DateJan 14, 2025

The dangerous pursuit of muscularity in men and adolescent boys

A systematic review found that exposure to social media posts depicting ideal muscular male bodies is directly linked to a negative body image and greater odds of resorting to anabolic-androgenic steroid use. Men are also under pressure to be physically strong, which is intrinsically linked to masculinity.

SourceFlinders University·JournalPsychology of Men & Masculinity·TypeSystematic review·DateOct 29, 2024

Risks faced by women using anabolic steroids in Australia

A new study reveals critical insights into the challenges faced by women who use anabolic-androgenic steroids (AAS) in Australia, highlighting a significant knowledge gap in sports medicine. The research emphasizes the need for tailored harm-reduction interventions and education on AAS use to mitigate risks associated with counterfeit ...

SourceGriffith University·JournalDrug and Alcohol Review·TypeCase study·DateAug 27, 2024

New guidance for healthcare professionals to address muscle-building supplement use

The University of Toronto has introduced comprehensive guidelines for healthcare professionals to address muscle-building supplement use among adolescents and young adults. These guidelines focus on assessment and harm reduction strategies to better support young individuals engaged in the use of these supplements. Healthcare professio...

SourceUniversity of Toronto·JournalJournal of Adolescent Health·DateJul 10, 2024

Repeated thoracic paravertebral blocking to alleviate pain symptoms in 66-years-old man with post-herpetic neuralgia: A case report

A case report describes the successful use of thoracic paravertebral blocking to manage severe chronic pain associated with post-herpetic neuralgia. The procedure, involving repeated injections of levobupivacaine and dexamethasone, resulted in significant pain subsidence and reduced medication needs.

SourceBentham Science Publishers·JournalThe Open Anesthesia Journal·DateMay 31, 2024

Rheumatism: Taking cortisone with antacids can diminish bone density

A Charité study found that taking proton pump inhibitors (PPIs) simultaneously with cortisone preparations is associated with a higher risk of osteoporosis in patients with inflammatory rheumatic conditions. The study analyzed the bone health of over 1,500 patients and found that PPI use led to significantly lower bone density.

SourceCharité - Universitätsmedizin Berlin·JournalMayo Clinic Proceedings·TypeObservational study·DateMay 16, 2024

Major breakthrough for severe asthma treatment

A landmark study found that 92% of patients with severe asthma can safely reduce inhaled steroid dose and more than 60% can stop all use, minimizing side effects like osteoporosis, diabetes, and cataracts. The SHAMAL study used biologic therapy benralizumab to control severe asthma without steroids.

SourceKing's College London·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateDec 8, 2023

Breakthrough for ‘neglected’ rheumatic condition

A year-long clinical trial found sustained remission of polymyalgia rheumatica in 28% of patients taking sarilumab, compared to 10% of those on placebo. The treatment showed promise in reducing relapse and improving outcomes for patients tapering their steroid medication.

SourceAnglia Ruskin University·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 25, 2023

Social determinants of health contribute to higher CVD mortality rates in Black persons

A large US study found that social determinants of health are a major factor contributing to higher cardiovascular disease mortality rates in Black individuals compared to Whites. The study analyzed data from over 50,000 adults and found significant associations between social factors such as unemployment and food insecurity with CVD m...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateAug 14, 2023

Retina cell breakthrough could help treat blindness

Researchers from Anglia Ruskin University have successfully grown retinal pigment epithelial cells on a nanofibre scaffold treated with fluocinolone acetonide, showing increased resilience and growth. This breakthrough technology has great potential for developing ocular tissue transplantation to treat age-related macular degeneration.

SourceAnglia Ruskin University·JournalMaterials·TypeExperimental study·DateJul 28, 2023

Skin lightening products can be dangerous, but users don’t know risks

A new study found that 21.3% of respondents used skin lightening agents, often for conditions like acne or hyperpigmentation, but most users were unaware of potential toxic ingredients and risks. The study highlights the need for cultural mindfulness in dermatology care to ensure safe and effective treatment across all communities.

SourceNorthwestern University·JournalInternational Journal of Women’s Dermatology·TypeSurvey·DateJul 13, 2023

Polymyalgia Rheumatica could be safely, effectively treated with tofacitinib, avoiding the need for steroids, per new proof-of-concept Randomized Controlled Trial

A new proof-of-concept Randomized Controlled Trial found tofacitinib effective and safe for Polymyalgia Rheumatica treatment, potentially avoiding steroid use. The study's results suggest a promising alternative treatment option for patients with this condition.

SourcePLOS·JournalPLOS Medicine·TypeRandomized controlled/clinical trial·DateJun 29, 2023

Pulsed radiofrequency with steroid injection brings sciatica relief

A new study published in Radiology found that a minimally invasive procedure combining pulsed radiofrequency and epidural steroid injection treatment leads to better pain reduction and disability improvement. The results showed significant benefits at four, 12, and 52 weeks compared to steroid injections alone.

SourceRadiological Society of North America·JournalRadiology·TypeRandomized controlled/clinical trial·DateMar 28, 2023

Journal of Pharmaceutical Analysis studies explore key traditional and modern therapeutics

Studies elucidate key aspects of traditional Chinese compounds and modern cancer therapeutics, highlighting the efficacy of R. serra in treating colitis and identifying active components of Gan Cao in treating pneumonia. A new radiolabeled antibody-based probe for detecting PD-L1 expression in cancers also provides a novel approach to ...

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateFeb 14, 2023

Neurosteroid deficits leads to depressed behavior

A study in mice found that chronic stress impairs allopregnanolone production, a key neurosteroid involved in regulating emotions. This finding suggests that synthetic neurosteroid analogs might exert a beneficial effect in individuals with depression.

SourceTufts University·JournalBiological Psychiatry·TypeRandomized controlled/clinical trial·DateFeb 13, 2023

New University of Ottawa research provides theory on why women stopped menstruating upon arrival at Nazi death camps

A new paper published in Social Science & Medicine proposes that synthetic steroids were administered to female captives in Nazi concentration camps to prevent menstruation and fertility. The study, led by Dr. Peggy J. Kleinplatz, is based on historical evidence and testimony from Holocaust survivors, who reported suspicious food ratio...

SourceUniversity of Ottawa·JournalSocial Science & Medicine·TypeSurvey·DateSep 20, 2022

Potential long-term treatment for asthma found

Researchers at Aston University have developed a new approach to tackle one of the underlying causes of asthma, not just its symptoms. The treatment, which targets the structural changes made by asthmatic airways, shows promising results in mice, reducing symptoms within two weeks and returning airways to near normal.

SourceAston University·JournalRespiratory Medicine·TypeExperimental study·DateAug 9, 2022